Moxibustion for rheumatic conditions: a systematic review and meta-analysis
Choi et al. · Clinical Rheumatology · 2011
OBJECTIVE
To evaluate the efficacy of moxibustion in the treatment of rheumatic conditions through systematic review and meta-analysis
WHO
Patients with rheumatoid arthritis, knee osteoarthritis, ankylosing spondylitis, gouty arthritis, and fibromyalgia
DURATION
Search through May 2010; studies ranging from 15 days to 6 months of treatment
POINTS
Points based on Traditional Chinese Medicine, using direct and indirect moxibustion
🔬 Study Design
Moxibustion
n=315
Moxibustion alone or combined with medications
Control
n=316
Conventional medications (NSAIDs, DMARDs)
📊 Results in numbers
Response rate vs. medications
Knee osteoarthritis
Moxibustion + medications vs. medications
High heterogeneity
Percentage highlights
📊 Outcome Comparison
Overall response rate
This review analyzed 14 studies on moxibustion (a technique that uses heat from burning herbs on specific points) for rheumatic pain. The results suggest that moxibustion may help, especially in knee osteoarthritis, but the quality of the studies was low, making the conclusions uncertain.
Article summary
Plain-language narrative summary
Moxibustion is a therapy from traditional East Asian medicine that uses heat generated by burning herbal preparations, primarily containing Artemisia vulgaris, applied to specific points on the body. Traditionally, this technique has been used to treat various rheumatic conditions, including rheumatoid arthritis, osteoarthritis, fibromyalgia, and other diseases that affect joints and muscles. Rheumatic conditions comprise more than 150 diseases and syndromes, generally progressive and associated with pain, including osteoporosis, lupus, and gout. People with severe chronic rheumatic conditions are particularly likely to seek complementary therapies such as moxibustion, especially because of the limitations and side effects of conventional treatments.
This study represents the first systematic review specifically on the efficacy of moxibustion for rheumatic conditions. The objective of the research was to gather and critically evaluate all available scientific evidence on the use of moxibustion as a symptomatic treatment for rheumatic conditions. The researchers conducted a comprehensive search across 14 medical databases, including Western and East Asian databases, from the inception of each database through May 2010, without language restrictions. Only randomized clinical trials testing moxibustion as a single treatment or combined with conventional medications, comparing with control groups receiving standardized medications, were included.
The methodological quality of the studies was assessed using rigorous criteria from the Cochrane Collaboration, and where appropriate, data were combined in meta-analyses to obtain more robust conclusions.
The search identified 14 randomized clinical trials that met the inclusion criteria, covering a total of 972 patients with various rheumatic conditions. The studies covered knee osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, gouty arthritis, and fibromyalgia. All studies were conducted in China and were based on Traditional Chinese Medicine principles for the selection of application points. The meta-analysis of the eight studies that compared moxibustion with drug therapy showed favorable effects of moxibustion on treatment response rate.
When analyzed by disease subgroups, moxibustion showed significant effects for knee osteoarthritis, but did not demonstrate clear efficacy for rheumatoid arthritis or ankylosing spondylitis. Six studies that tested moxibustion combined with medications versus medications alone also suggested beneficial effects of the combination. Only two studies reported adverse effects, indicating that moxibustion appeared to be safe in the contexts studied.
The results suggest that moxibustion may be a promising therapeutic option for certain rheumatic conditions, particularly knee osteoarthritis. For patients living with chronic pain and functional limitations, these findings offer hope for an alternative or complement to conventional treatments. Moxibustion may be especially attractive for people who experience side effects from anti-inflammatory medications or who seek more natural approaches to pain control. For healthcare professionals, the results indicate that moxibustion may be considered as part of an integrated treatment plan, especially when combined with conventional therapies.
However, it is important that qualified professionals perform the assessment and application of the technique, following Traditional Chinese Medicine principles for the appropriate selection of treatment points. The apparent safety of the technique, as indicated by the few reported adverse effects, is also encouraging for its clinical application.
However, the study has significant limitations that should be considered in the interpretation of the results. All included studies had low methodological quality, with significant problems in randomization, allocation concealment, and lack of adequate blinding. The impossibility of blinding patients and therapists with regard to the application of moxibustion represents an inherent challenge in this type of research, as participants know they are receiving the treatment. In addition, all studies were conducted in China, where negative results in traditional medicine research are rarely observed, which raises concerns about possible publication bias.
The total number of participants across studies was relatively small, and there was high heterogeneity among studies, making it difficult to generalize the results. None of the studies used appropriate placebo controls to differentiate specific effects of moxibustion from non-specific effects, such as the additional attention received by patients.
In conclusion, although the results suggest promising effects of moxibustion for rheumatic conditions, particularly knee osteoarthritis, current evidence is insufficient to establish definitive conclusions about its efficacy. The findings should be interpreted with caution due to the significant methodological limitations of the included studies. Future studies are needed and should overcome these methodological shortcomings, including better randomization, appropriate placebo controls, larger samples, and evaluation by independent investigators. Patients interested in moxibustion should discuss this option with their physicians, considering it as a complement, not a substitute, to established conventional treatments.
The technique appears to be safe when applied appropriately, but more high-quality research is needed to definitively determine its place in the treatment of rheumatic conditions.
Strengths
- 1First specific review on moxibustion for rheumatic conditions
- 2Comprehensive search across 14 databases including Chinese-language literature
- 3Meta-analysis with subgroup analysis by condition
- 4Rigorous methodological quality assessment
Limitations
- 1All studies presented a high risk of methodological bias
- 2All studies originated from China, limiting generalizability
- 3High heterogeneity across studies (I²=58-62%)
- 4Lack of adequate sham control groups
- 5No study reported ethical approval
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
Moxibustion occupies a therapeutic space that deserves growing attention in the management of chronic rheumatic conditions, particularly in knee osteoarthritis — one of the most prevalent complaints in physiatry and pain clinics. This meta-analysis shows that moxibustion, compared with conventional pharmacotherapy, achieves a superior response rate with an RR of 1.13, and that its combination with conventional medications raises that effect to an RR of 1.25. For the clinician treating patients with symptomatic osteoarthritis refractory to NSAIDs, with contraindications to anti-inflammatories due to renal or cardiovascular comorbidities, or with limited tolerance to DMARDs, these data justify incorporating moxibustion as an adjuvant component of the treatment plan. The elderly population with polyarthritis and progressive functional limitation is especially eligible for this integrated approach.
▸ Notable Findings
The finding that most catches my attention in this review is the heterogeneity of response across the rheumatic conditions analyzed. While knee osteoarthritis demonstrated a statistically significant and consistent benefit — an RR of 1.08 with a confidence interval that does not cross unity — the analyses for rheumatoid arthritis and ankylosing spondylitis did not reach significance. This suggests that the effect of moxibustion is not generic across 'rheumatism' but is possibly mediated by thermoreceptor and local anti-inflammatory mechanisms more relevant in weight-bearing peripheral synovial joints. The superiority of moxibustion plus medication over medication alone, with an RR of 1.25, also reinforces the multimodality logic guiding contemporary treatment of chronic musculoskeletal pain, suggesting synergy between mechanisms of action.
▸ From My Experience
In my practice in the musculoskeletal pain clinic, I have incorporated moxibustion as an adjuvant resource mainly in patients with grade II-III knee osteoarthritis who have already exhausted first-line pharmacological management and are awaiting surgical evaluation or are not candidates for it. I tend to observe a perceptible response — functional improvement and reduced morning stiffness — between the third and fifth session, with cycles of eight to twelve sessions to consolidate the effect. I routinely combine it with supervised aquatic exercise and orthoses, and occasionally with electroacupuncture at distal points to potentiate the segmental analgesic effect. The profile of patient who responds best, in my observation, is the one with a prominent local inflammatory component and predominantly mechanical pain, without marked central sensitization. Patients with fibromyalgia or predominant central pain rarely respond satisfactorily, which is consistent with the absence of significant effect for that condition in the data of this review.
Full original article
Read the full scientific study
Clinical Rheumatology · 2011
DOI: 10.1007/s10067-011-1706-5
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories